Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Int J Immunogenet ; 44(6): 350-355, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29105301

RESUMEN

The effect of HLA-G 14 bp Ins/Del polymorphism (rs371194629) on the risk of preeclampsia has been assessed in several populations, yet the results are still conflicting. Lack of power due to small sample sizes is a common cause of inconsistencies in genetic association studies. We aimed to test whether the maternal polymorphism is associated with preeclampsia, eclampsia or HELLP syndrome (acronym for Hemolysis, Elevation of Liver enzymes, Low Platelets). To achieve a statistical power greater than 0.90, a total of 741 women (332 controls, 246 preeclampsia, 57 eclampsia and 106 HELLP) were genotyped for the 14-bp Ins/Del polymorphism. The genetic association with disease status was assessed by Fisher's exact test and odds ratio (OR) estimates using logistic regression model adjusted for maternal age and parity status. Allele and genotype distributions were the same between control and case groups (p > .05). The polymorphism was not associated with the risk of developing preeclampsia [OR = 0.93 (0.72-1.19); p = .541], or eclampsia [OR = 0.90 (0.60-1.38); p = .628] nor HELLP syndrome [OR = 0.92 (0.66-1.28); p = .628]. This well-powered study clearly demonstrates that the maternal HLA-G 14-bp Ins/Del polymorphism is not associated with preeclampsia risk. However, as the offspring genotypes were not evaluated here, we could not rule out the effect of the foetal genotype on the preeclampsia pathogenesis.


Asunto(s)
Emparejamiento Base/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Antígenos HLA-G/genética , Mutación INDEL/genética , Polimorfismo Genético , Preeclampsia/genética , Eliminación de Secuencia/genética , Adulto , Alelos , Femenino , Humanos , Modelos Logísticos , Edad Materna , Fenotipo , Embarazo , Factores de Riesgo , Adulto Joven
2.
Reprod Domest Anim ; 52 Suppl 4: 75-77, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29052320

RESUMEN

The study aimed to assess whether altrenogest treatment, fed before weaning (from -8 to -2 days), could improve fertility of sows showing reproductive seasonality. Ninety sows (50 in winter-spring [WS] and 40 in summer-autumn [SA]) were randomly selected and assigned to control (C; 27 in WS and 20 in SA) or altrenogest treatment (A; 23 in WS and 20 in SA) groups. The diameter and number of ovarian follicles were transrectally scanned at the onset of oestrus. Oestrus was evaluated twice daily from weaning to day 8 post-weaning. Sows in oestrus were post-cervically inseminated at 0 and 24 hr after the onset of oestrus with liquid stored semen (1.5 × 109 sperm/doses), and farrowing rates (FR) and total piglets born (LS) were recorded. More (p < .01) sows showed no signs of oestrus within 8 days after weaning in SA (30%) than in WS (2%), without differences between A and C groups. The diameter (cm) of the follicles at the onset of oestrus was larger in A than in C sows (0.76 ± 0.01 vs 0.73 ± 0.01; p < .01), irrespective of the season. No differences in the number of follicles were found. FR did not differ between seasons and groups, being always above 85%. LS was larger (p < .01) in A (14.00 ± 0.46) than C (12.27 ± 0.44) sows, irrespective of the season. In conclusion, a short-term altrenogest treatment at the end of lactation improves the total number of piglets born from weaned sows, probably by promoting a better and more homogeneous follicular development at the start of oestrus.


Asunto(s)
Tamaño de la Camada , Folículo Ovárico/efectos de los fármacos , Progestinas/farmacología , Sus scrofa , Acetato de Trembolona/análogos & derivados , Animales , Estro/efectos de los fármacos , Femenino , Inseminación Artificial/veterinaria , Lactancia/fisiología , Masculino , Folículo Ovárico/fisiología , Embarazo , Progestinas/administración & dosificación , Acetato de Trembolona/farmacología
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda